Skip to main content

Groupe la Francaise

Position in PFE — Pfizer Inc

CIK 2056088 PARIS, I0

Position in PFE

as of Mar 31, 2026 · filed May 21, 2026
Position Value
$510,297
+$22,955 QoQ
Shares Held
18,173
-7.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority Sole 47.56506905849337.ToString("F0")% Shared 0.ToString("F0")% None 52.43493094150663.ToString("F0")%

Common Shares in PFE Over Time

Shares Held

Position Value (USD)

Derivatives in PFE

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$1,038,960
PutShares
37,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

Groupe la Francaise holds $378,895,176 across 11 Drug Manufacturers - General names. PFE ranks #8 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 PFE
Pfizer Inc
This page
18,173 $510,297

All Filings in PFE

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,038,960 37,000
2026-03-31 $510,297 18,173
2025-12-31 $921,300 37,000
2025-12-31 $487,342 19,572
2025-09-30 $382,200 15,000
2025-09-30 $1,972,865 77,428
2025-06-30 $363,600 15,000
2025-06-30 $600,545 24,775
2025-03-31 $4,110,476 162,213
2024-12-31 $3,791,720 142,922